Concepedia

Maria Rojeski

MR

Statistics

Publications

13

Citations

898

H-Index

13

Active since

1988

Affiliations

UCB Pharma (Belgium)(Current)

Amgen (United States)

Sanofi (France)

Sanofi (United States)

Aarhus University Hospital

Maria Rojeski is an author at UCB Pharma (Belgium) specializing in medicine, bone health, and obstetrics.

Top concepts

Publications per year

1988–2022

13

Publications

13

Receptors for Insulin-like Growth Factors I and II: Autoradiographic Localization in Rat Brain and Comparison to Receptors for Insulin*

Maxine A. Lesniak, Joanna M. Hill, Maria Rojeski et al. · Endocrinology · 1988 · 252 citations

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Philip Home, Richard M. Bergenstal, Geremia B. Bolli et al. · Diabetes Care · 2015 · 219 citations · Full text

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Felicia Cosman, David L. Kendler, Bente Langdahl et al. · Osteoporosis International · 2022 · 98 citations · Full text

Insulin-Like Growth Factor-II in Nonislet Cell Tumors Associated with Hypoglycemia: Increased Levels of Messenger Ribonucleic Acid*

William L. Lowe, Charles T. Roberts, Derek LeRoith et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 57 citations

<i>T</i>-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial

Felicia Cosman, E. Michael Lewiecki, Peter R. Ebeling et al. · Journal of Bone and Mineral Research · 2020 · 52 citations · Full text

1–5 of 13